Balaji Amines Ltd

Balaji Amines Q3FY26 Results: Revenue at ₹331.30 Cr, EBITDA Margin 18.34% 📊

• Q3FY26 revenue: ₹331.30 crore (down from ₹340.55 crore in Q2FY26)

• Stable volumes maintained at 25,894 MT

• Q3FY26 EBITDA: ₹61.67 crore with margin of 18.34%

• Q2FY26 EBITDA: ₹66.87 crore; Q3FY25 EBITDA: ₹53.57 crore

• Profit after tax (PAT) for Q3FY26: ₹30.76 crore

• Company is debt-free on standalone basis

• New projects: Dimethyl Ether (DME) plant, N-Methyl Morpholine (NMM) facility, and Acetonitrile (ACN) upgrade

• Expected commissioning of new projects in FY2026-27

• Subsidiary Balaji Speciality Chemicals expanding with ₹750 crore investment for Hydrogen Cyanide and Sodium Cyanide production

• Export revenue accounted for 12.80% of total FY25 revenue (₹165.96 crore)

• Presence in over 50 countries

• Commissioned 8 MW DC solar power plant to reduce energy costs and carbon footprint